4//SEC Filing
Bison Capital Holding Co Ltd 4
Accession 0001213900-19-009295
CIK 0001697805other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 1:58 PM ET
Size
8.9 KB
Accession
0001213900-19-009295
Insider Transaction Report
Form 4
Bison Capital Holding Co Ltd
10% OwnerOther
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2019-05-15+108,980→ 1,628,580 total - Purchase
Warrants
2019-05-15$11.50/sh+25,000$287,500→ 225,937 totalExercise: $11.50→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]In connection with the closing of a business combination with Xynomic Pharmaceuticals, Inc., Bison Capital Holding Company Limited, a Cayman Islands company ("Bison Capital"), purchased 13,793 shares (the "Backstop Shares") of common stock of Bison Capital Acquisition Corp., a Delaware corporation (now known as Xynomic Pharmaceuticals Holdings, Inc., the "Company"), par value $0.001 per share pursuant to a Backstop and Subscription Agreement dated May 1, 2019 between the Company and Yiling Mark Xu and converted its $500,000 promissory notes issued by the Company into 55,000 common shares and 25,000 warrants, each exercisable to purchase one share of common stock at $11.50 per whole share.
- [F2]Pursuant to the promissory note and warrant agreement, each unit consists of one share; each whole warrant entitles the holder to one common share exercisable at $11.50 per share, expiring at the 5th anniversary of the business combination.
- [F3]Fengyun Jiang, who has 100% ownership interest in Bison Capital and is Peixin Xu's spouse, has voting and dispositive power over the shares held by such entity. Mr. Xu was the Chairman of the Company but resigned at the closing of a business combination, effective May 15, 2019.
Documents
Issuer
XYNOMIC PHARMACEUTICALS HOLDINGS, INC.
CIK 0001697805
Entity typeother
IncorporatedChina
Related Parties
1- filerCIK 0001593415
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 1:58 PM ET
- Size
- 8.9 KB